Alzheimer Disease Clinical Trial
Official title:
Efficacy of a High-Intensity Interval Exercise Program Versus a Dual-Task Training Program in People With Alzheimer's: A Randomized Clinical Trial
NCT number | NCT05691842 |
Other study ID # | 1686728 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | December 20, 2022 |
Est. completion date | January 2026 |
Alzheimer's disease (AD) is a the most common type of dementia. It is a progressive disease that affects different areas of human behavior at the cognitive, social, physical and metabolic levels. The benefits of a High-Intensity Interval Exercise Program (HIIT) has been proven not only in healthy older adults, but also in different pathologies, such as cerebrovascular and cardiometabolic diseases. However, there are no studies to date that examine the impact of HIIT in people with AD. The aim of this study was to ascertain the effectiveness of a HIIT program versus a cognitive and motor dual task balance program on parameters related to functional capacity and cognitive function in people with AD.
Status | Recruiting |
Enrollment | 66 |
Est. completion date | January 2026 |
Est. primary completion date | November 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Years to 90 Years |
Eligibility | Inclusion Criteria: - Aged between 60 -90 years - Diagnosed with mild or moderate AD according to the Clinical Dementia Rating (CDR1). - Ability to follow the instructions of the training program. - Ability to get up from a chair alone. - Independent ambulation. - Providing signed informed consent. Exclusion Criteria: - Dementia or severe cognitive impairment that makes it impossible to understand instructions. - Presence of other neurological pathologies such as: stroke, Parkinson's or cranioencephalic trauma. - Severe cardiovascular disorders. - Severe visual deficits. - Vertigo - Other limitations that make it difficult to ambulate. - Participating in any high intensity exercise program. |
Country | Name | City | State |
---|---|---|---|
Spain | Faculty of Physiotherapy, University of Valencia | Valencia |
Lead Sponsor | Collaborator |
---|---|
University of Valencia |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline cardiorespiratory fitness | 6 minutes walking test" (6MWT): distance (m) | At baseline, immediately after the intervention and at 2 month-follow-up | |
Primary | Change from baseline balance ability | Star Excursion Balance Test: maximal distance in all directions (cm), 3 times | At baseline, post-intervention and at 2 month-follow-up | |
Secondary | Change from baseline lower limb isometric strength | Lafyette dynamometer: quadriceps, hamstrings, gastrocnemius,tibialis anterior | At baseline, immediately after the intervention and at 2 month-follow-up | |
Secondary | Change from baseline lower limb power | 30 Second Sit to Stand Test: number of times the patient comes to a full standing position in 30 seconds | At baseline, immediately after the intervention and at 2 month-follow-up | |
Secondary | Change from baseline Risk of Falling | Timed up and go: time (in seconds) that a person takes to rise from a chair, walk three meters, turn around 180 degrees, walk back to the chair, and sit down while turning 180 degrees. An older adult who takes =12 seconds to complete the TUG is at risk for falling | At baseline, immediately after the intervention and at 2 month-follow-up | |
Secondary | Fall frequency | Fall diary. The individual is asked to write down how many times he/she falls during a period. | Daily for 12 weeks (the length of the intervention) | |
Secondary | Change from baseline Fear of falling | Falls Eficacy Scale International. It is a 16 item questionnaire, useful to the researchers and clinicians interested in fear of falling, with a score ranging from minimum 16 (no concern about falling) to maximum 64 (severe concern about falling) | At baseline, immediately after the intervention and at 2 month-follow-up | |
Secondary | Change from baseline Cognitive status | Mini-Mental State Examination: The Mini-mental state examination is scored on a scale of 0-30 with scores > 24 interpreted as normal cognitive status. | At baseline, immediately after the intervention and at 2 month-follow-up | |
Secondary | Change from baseline Executive function status | Stroop test: Three scores, as well as an interference score, are generated using the number of items completed on each page, with higher scores reflecting better performance and less interference on reading ability. | At baseline, immediately after the intervention and at 2 month-follow-up | |
Secondary | Change from baseline depression levels | Geriatric Depression Scale (15-item scale): This scale is scored form 0 to 15. A score higher than 5 points suggests depression. | At baseline, immediately after the intervention and at 2 month-follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |